The distinctive nature of HER2-positive gastric cancers

被引：13
|
作者：
Marano, L. [1 ]
Roviello, F. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源：
EJSO | 2015年 / 41卷 / 03期
关键词：
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I：
10.1016/j.ejso.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [41] Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers
    Zacarias-Fluck, Mariano F.
    Morancho, Beatriz
    Vicario, Rocio
    Luque Garcia, Antonio
    Escorihuela, Marta
    Villanueva, Josep
    Rubio, Isabel T.
    Arribas, Joaquin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
  • [42] Early HER2-positive breast cancers: time for a new revolution?
    Gligorov, Joseph
    LANCET ONCOLOGY, 2018, 19 (01): : 12 - 13
  • [43] Pertuzumab (Perjeta®) approval in HER2-positive metastatic breast cancers
    Sabatier, Renaud
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (7-8) : 765 - 771
  • [44] Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers
    Irkkan, Cigdem
    Balci, Serdar
    Tezel, Gaye Guler
    Akinci, Bulent
    Yalcin, Bulent
    Guler, Gulnur
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (09) : 609 - 614
  • [45] The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
    Castagnoli, Lorenzo
    Ladomery, Michael
    Tagliabue, Elda
    Pupa, Serenella M.
    CANCERS, 2019, 11 (07)
  • [46] Clinical outcome of optimally treated HER2-positive and HER2-negative breast cancers
    So, Alycia
    Williams, Austin
    Li, Yun
    Carrigan, Elena
    Steel, Laura
    Zhang, Paul
    Tchou, Julia
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 316 - 318
  • [47] HER2-positive gastric cancer identified by serum HER2: A case report
    Saito, Mayuko
    Kawakami, Yujiro
    Yamashita, Kentaro
    Nasuno, Hiroshi
    Ishimine, Yu
    Fukuda, Koichiro
    Isshiki, Hiroyuki
    Suzuki, Ryo
    Arimura, Yoshiaki
    Shinomura, Yasuhisa
    ONCOLOGY LETTERS, 2016, 11 (06) : 3575 - 3578
  • [48] Resistance mechanisms to HER2-targeting treatment in HER2-positive gastric cancer
    Kang, Kyo Hwa
    Nam, Ah-Rong
    Park, Ji Eun
    Bang, Ju-Hee
    Ling, Jin
    Jin, Mei Hua
    Kim, Tae Yong
    Han, Sae-Won
    Song, Sang-Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER RESEARCH, 2015, 75
  • [49] Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2-positive cancers
    Blasquez, Lucas
    Bouzinba-Segard, Haniaa
    Bourdoulous, Sandrine
    Faure, Camille
    MOLECULAR ONCOLOGY, 2023, 17 (10) : 1981 - 1999
  • [50] Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Namba, Kei
    Torigoe, Hidejiro
    Sato, Hiroki
    Tomida, Shuta
    Yamamoto, Hiromasa
    Asano, Hiroaki
    Soh, Junichi
    Tsukuda, Kazunori
    Nagasaka, Takeshi
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER SCIENCE, 2018, 109 (04) : 1166 - 1176
12345